The HIV Vaccine Trials Network (HVTN) will host its 10^th Translational HIV Vaccine Early Stage Investigator (ESI) Conference in San Antonio, Texas from October 19-20, 2026, prior to the NHP AIDS Symposium, which will occur from October 20-23, 2026.

ATTENTION – DEADLINE APPROACHING – JUNE 1:

The HVTN will provide a limited number of travel awards to attend this conference. This award will cover airfare, hotel, registration fees for the NHP AIDS Symposium, ground transportation, and per diem. The application is now open at the following link, and the deadline to apply is Monday, June 1: 2026 ESI Conference Travel Award Application

This conference is intended for ESIs who focus on translational HIV research in non-human primates (NHPs), or clinical HIV and TB research, and are within 10 years of completing their terminal research degree (PhD, MD, DVM), medical residency, or equivalent. Investigators will participate in career mentoring and networking designed for ESI working in translational HIV research. Past attendees have stated that the Conference has increased their skills and knowledge for career development and provided them with a venue to form new collaborations. 

Click here for ESI Conference webpage

Registration is now open at the following link: 2026 ESI Conference Registration

Click here for the time in your location.

Powerful research focused on transgender people was presented at CROI 2026. Join this webinar to hear from three scientists who shared their work, exploring everything from cervical tissues to healthcare policies and community priorities beyond HIV prevention and care.

REGISTER HERE

A recently published study in Journal of Empirical Research on Human Research Ethics examines how research incentives are understood and experienced in HIV research by people living with HIV (PLWH), institutional review board (IRB) members, and researchers. The study found that IRB members and researchers were most concerned about incentives being too high, while PLWH were more concerned about incentives being too low, which they felt could undermine trust and feel exploitative. Across all groups, participants emphasized the need for greater transparency, clearer guidance, and stronger community engagement in determining incentive amounts. Together, these insights highlight the importance of aligning ethical decision‑making with community priorities to strengthen trust in HIV research. This webinar will include a summary of the study findings, as well as actionable steps to determine ethical incentives for research participation.

REGISTER HERE